Restore Robotics Received FDA 510(k) Clearance for Two Additional da Vinci Xi® Robotic Instruments
On 31 March 2026, Restore Robotics announced that it had received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the remanufacturing of two more da Vinci Xi robotic surgical instruments. This achievement expanded the company’s portfolio of cleared instruments and reinforced its position in the robotic instrument remanufacturing space.
With these new clearances, the company continued to advance its mission of providing hospitals and surgical centers with cost-effective, high-quality, and sustainable alternatives to purchasi...
